- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.07. | Cannabis Bioscience International Holdings: CBIH Unveils Cannabinoid-Based Intranasal Platform for Alzheimer's Research | 170 | Newsfile | Houston, Texas--(Newsfile Corp. - July 20, 2026) - Alzheimer's disease is not only a scientific challenge; it is a human crisis affecting millions of patients, families, caregivers, and healthcare... ► Artikel lesen | |
| 15.07. | Cannabis Bioscience International Holdings: Years of Preparation. One Regulatory Approval. Commercial Launch Begins: CBIH Receives Texas License for Consumable Hemp Products | 197 | Newsfile | Houston, Texas--(Newsfile Corp. - July 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today... ► Artikel lesen | |
| 06.07. | Cannabis Bioscience International Holdings: CBIH Announces Recognition Initiative Funded Through CEO's Personal Share Holdings | 254 | Newsfile | Houston, Texas--(Newsfile Corp. - July 6, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announces... ► Artikel lesen | |
| 22.06. | Cannabis Bioscience International Holdings: Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement | 231 | Newsfile | Houston, Texas--(Newsfile Corp. - June 22, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today... ► Artikel lesen | |
| 15.06. | Cannabis Bioscience International Holdings: CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research | 302 | Newsfile | Houston, Texas--(Newsfile Corp. - June 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading under the ticker symbol CBIH, today announced a new chapter... ► Artikel lesen | |
| 08.06. | Cannabis Bioscience International Holdings: CBIH Advances Strategic Pathway to Bring VitaCookies' Science-Driven Functional Wellness Platform to Texas Consumers | 264 | Newsfile | Houston, Texas--(Newsfile Corp. - June 8, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public biotechnology company trading under the ticker symbol CBIH, today announced... ► Artikel lesen | |
| CANNABIS BIOSCIENCE INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
| 01.06. | Cannabis Bioscience International Holdings: CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on Cannabinoid Science and Epigenetic Regulation | 206 | Newsfile | Houston, Texas--(Newsfile Corp. - June 1, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company focused on cannabinoid biotechnology, applied research, and therapeutic... ► Artikel lesen | |
| 16.04. | Cannabis Bioscience International Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.04. | Cannabis Bioscience International Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 19.02. | Cannabis Bioscience International Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.01. | Cannabis Bioscience International Holdings: CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence | 247 | Newsfile | Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced... ► Artikel lesen | |
| 05.01. | Cannabis Bioscience International Holdings: CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition | 294 | Newsfile | Houston, Texas--(Newsfile Corp. - January 5, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today... ► Artikel lesen | |
| 29.12.25 | Cannabis Bioscience International Holdings: CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways | 422 | Newsfile | Houston, Texas--(Newsfile Corp. - December 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today... ► Artikel lesen | |
| 22.12.25 | Cannabis Bioscience International Holdings: CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities | 342 | Newsfile | Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces a landmark corporate and industry moment following recent indications... ► Artikel lesen | |
| 13.10.25 | Cannabis Bioscience International Holdings: CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery | 454 | Newsfile | Houston, Texas--(Newsfile Corp. - October 13, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) today announced the addition of a patent-pending nanoemulsion formulation to its... ► Artikel lesen | |
| 06.10.25 | Cannabis Bioscience International Holdings, Inc. Appoints Veteran Financier Andy Trivedi to Its Board of Directors, Strengthening Capital Strategy and Growth Outlook | 355 | Newsfile | Houston, Texas--(Newsfile Corp. - October 6, 2025) - Cannabis Bioscience International Holdings, Inc., (OTCID: CBIH), a publicly traded biomedical cannabis research and development company listed on... ► Artikel lesen | |
| 29.09.25 | Cannabis Bioscience International Holdings: CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center | 279 | Newsfile | Houston, Texas--(Newsfile Corp. - September 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) announces a Statewide Educational Seminar Series on the TCUP Expansion, as Texas... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 49,810 | +0,83 % | DAX vor spannender Woche - und Rekorden? Bayer, Siemens Energy, Commerzbank und Allianz mit ... | Ungeachtet der geopolitischen Krisenherde könnte die überwiegend positiv aufgenommene Berichtssaison der DAX-Konzern auch in der neuen Woche Rückenwind verleihen. Sinkende Ölpreise und starke Quartalszahlen... ► Artikel lesen | |
| MERCK KGAA | 143,65 | -1,03 % | Neue Folge "Börse, Baby!": Earnings-Alarm: Jetzt entscheidet sich der KI-Boom | Die KI-Euphorie bekommt erste Risse: Trotz starker Quartalszahlen geraten Tech-Aktien kräftig unter Druck. Ist das noch eine gesunde Korrektur? Die Berichtssaison zeigt derzeit, wie hoch die Erwartungen... ► Artikel lesen | |
| NOVO NORDISK | 40,970 | -0,06 % | Novo Nordisk, Johnson & Johnson und Co. setzen auf Plattformen - warum einzelne Medikamente für Big Pharma längst nicht mehr ausreichen | ||
| PFIZER | 23,100 | -0,15 % | Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound | ||
| BRIGHT MINDS BIOSCIENCES | 79,33 | 0,00 % | Motorola Solutions Foundation and Calculated Genius Honor Chicagoland Future Engineers With 2026 Bright Minds, Bold Futures Scholarship | NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Ten extraordinary Chicagoland high school seniors recently gathered at Motorola Solutions' global headquarters in Chicago, joined by family members... ► Artikel lesen | |
| ELI LILLY | 1.027,40 | +0,21 % | Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem | ||
| ZHENGYE BIOTECHNOLOGY | 1,890 | 0,00 % | Zhengye Biotechnology regains Nasdaq bid price compliance; shares down | ||
| ETON PHARMACEUTICALS | 44,560 | -0,09 % | Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 | ASN-001 targets the substantially larger population of moderate infantile hemangiomas currently treated off-label with topical timololComplementary product to HEMANGEOL (propranolol hydrochloride)... ► Artikel lesen | |
| SANOFI | 75,42 | -0,08 % | BERENBERG stuft SANOFI auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Sanofi auf "Buy" mit einem Kursziel von 105 Euro belassen. Angesichts der Stärke des Portfolios von bereits auf dem Markt... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 13,880 | -0,04 % | Kazia Therapeutics Limited: Kazia Therapeutics Appoints James Levine as Chief Financial Officer | SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company... ► Artikel lesen | |
| OMNIAB | 3,080 | 0,00 % | OmniAb GAAP EPS of -$0.05 beats by $0.07, revenue of $13.4M beats by $8.71M | ||
| LB PHARMACEUTICALS | 47,960 | -0,08 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Announces $150 Million Private Placement | NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact... ► Artikel lesen | |
| CANOPY GROWTH | 0,841 | -0,10 % | Canopy Growth übertrifft Gewinnerwartungen für Q1 2027 - Aktie legt zu | ||
| SCHOTT PHARMA | 22,500 | +2,74 % | UBS stuft Schott Pharma auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Schott Pharma von 25,90 auf 26,50 Euro angehoben und die Einstufung auf "Buy" belassen. Das neue Kursziel reflektiere den... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 3,945 | +0,13 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Reaffirms guidance to resubmit Anaphylm (dibutepinephrine) sublingual film NDA in Q3 2026Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union... ► Artikel lesen |
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS INC finden Sie auf Wallstreet Online.